Volitionrx

VNRXNYSE Singapore Health Care Biotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$9.338 M

$0.78 +1.21%

Close of 7 Aug 2026

Revenue

$1.73M

#3455 by revenue

Earnings

-$23.4M

Loss-making

Shares outstanding

158,481,243

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances — ranked by market cap

All 19 →

#13ImmucellICCC$99.5M
#14Q/C TechnologiesQCLS$22.9M
#15VolitionrxVNRX$9.34M
#16Trinity BiotechTRIB$8.39M
#17Cardio DiagnosticsCDIO$5.30M

Where these numbers come from

Share counts and financials for Volitionrx are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.